En­do con­sid­ers bank­rupt­cy fil­ing as it feels the heat from thou­sands of opi­oid law­suits — re­port

En­do In­ter­na­tion­al is re­port­ed­ly con­sid­er­ing fil­ing for bank­rupt­cy in an at­tempt to dig it­self out from bil­lions of dol­lars in debt and a moun­tain of opi­oid law­suits.

Un­named sources told the Wall Street Jour­nal that En­do is weigh­ing a Chap­ter 11 fil­ing as it con­tends with $8 bil­lion in debt. The com­pa­ny has al­so yet to set­tle thou­sands of law­suits over its opi­oid pain med Opana ER, which was tak­en off the mar­ket in 2017 at the FDA’s re­quest. En­do did not re­spond to an in­ter­view re­quest as of press time.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER